Impairment of FITM2 function is linked with metabolic disorders such as type-2 diabetes, insulin resistance, lipodystrophy, and non-metabolic diseases such as deafness-dystonia syndrome (Miranda et al., 2014; Zazo Seco et al., 2017; Zheng et al., 2022). This evidence concerns the gene FITM2 and metabolic disease.